Atopic Dermatitis Global Clinical Trials Review, H1, 2017

  • ID: 4307979
  • Clinical Trials
  • Region: Global
  • 413 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LEO Foundation
  • MORE
Atopic Dermatitis Global Clinical Trials Review, H1, 2017

Summary

The author's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H1, 2017" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astellas Pharma Inc
  • Bayer AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • LEO Foundation
  • MORE
Table of Contents
Table of Contents
List of Tables
List of Figures
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Atopic Dermatitis
Mar 16, 2017: Asana BioSciences Announces FDA Acceptance of the IND Application for its Novel SYK-JAK Inhibitor for Evaluation in Atopic Dermatitis
Mar 14, 2017: GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)
Mar 04, 2017: Sanofi and Regeneron Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of Dupixent (dupilumab) in Moderate-to-Severe Atopic Dermatitis
Mar 03, 2017: LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis
Mar 02, 2017: Chugai’s Anti-IL-31 Receptor A Humanized Monoclonal Antibody “nemolizumab (CIM331)” Global Phase II Study Data Published in The New England Journal of Medicine Online
Feb 28, 2017: FDA Permits Realm Therapeutics to Proceed to Phase II Clinical Trial with PR022 for Atopic Dermatitis
Feb 28, 2017: KPI Therapeutics Will Present New, Positive Data on KPI-150 as a Potential New Therapy for Atopic Dermatitis at Upcoming Skin Disease Conference
Feb 27, 2017: Regeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses
Feb 22, 2017: MatriSys Bioscience announces publication of highly promising results which could translate into clinically meaningful benefits for eighteen million patients with atopic dermatitis
Jan 30, 2017: Realm Therapeutics Submits Investigational New Drug Application for PR022 for Atopic Dermatitis
Clinical Trial Profile Snapshots
Appendix 4
Abbreviations 4
Definitions 4
Research Methodology 4
Secondary Research 4
About the Publisher 4
Contact Us 4
Source 4

List of Tables
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*
Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2017*
Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2017*
Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

List of Figures
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region (%), 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*
Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*
Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2017*
Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*
Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*
Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2017*
Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*
Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*
Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*
Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Sanofi
  • Regeneron Pharmaceuticals Inc
  • Astellas Pharma Inc
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • LEO Foundation
  • Bayer AG
  • Johnson & Johnson
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll